RemedyMD Insider

Webinar: Tools to Build Scalable Medical Research Databases and Registries

noreply@blogger.com (RemedyMD) — Thu, 14 Apr 2011 15:48:00 +0000

If you’re like most researchers (or IT professionals who support researchers), you need one or more registries specific to different areas of research. And you need a way to handle data collection requirements which could often change over time.

You probably also could benefit from accessing data kept in myriad sources like spreadsheets on different computers or servers, data in one or more Access databases, or other homegrown registries.

During this webinar, view first-hand how RemedyMD tools rapidly build registries for all specialized needs in a fraction of the time of one-off development. By employing a meta-registry model using the latest ORACLE technology, accessing all available data is not just easy, it's automatic for registries that are built using the same tool set.

Attend and witness how to have your perfect registry at a fraction of one-off development costs, in a fraction of the time. Plus, you get access to the integrated LIMS, ELN, and patient portal for managing studies, biospecimen, and patient-reported longitudinal data.

This webinar could accelerate your research forever and is not to be missed!

"Real" Registries Vs. Spreadsheets or Access Databases: Trading Up for Access to Clinical Data. April 7th, 3:00 PM (EST)

noreply@blogger.com (RemedyMD) — Thu, 10 Mar 2011 23:22:00 +0000

Researchers say they would give almost anything to gain access to clinical data. Would they give up their toys? One of the largest impediments to effective research is the inability to make use of existing clinical data. Are you able to link your existing research data that is stored in spreadsheets or little Access databases with the clinical data you need to be dramatically more effective? Perhaps the problem is not with the clinical data but instead is the toy registry you are trying to link with the clinical data. “Toy” registries enable you to house data that has no validation, terminological harmonization, or mechanism to harmonize your research data with the other disparate source of data. No wonder researchers feel they are spending more time as database administrators than as clinical researchers. The strength of using toy systems such as spreadsheets for research is that you can dump any kind of data into them which also happens to be the major drawback.

This webinar will demonstrate the capabilities you can get from a real, robust registry. You will see how clinical data can be accessed regardless of where it is stored or the formats it is kept in, and how this data can be efficiently ‘normalized’ and validated so running queries or reports across any data elements is simple. Configuring data capture forms and reports is as simple as dragging and dropping data elements from our ontology. Researchers will dramatically accelerate their results once using a ‘real’ registry, whether that work is basic science research, clinical research, disease or outcomes research, comparative effectiveness studies, clinical trials, or medical device research.

Seeing this breakthrough technology in contrast with ‘toy’ registries, spreadsheets, or Access databases is vital for understanding the opportunity costs of using such systems and benefitting from making the change. Register here.

Major Interest in Multiple Sclerosis Research

noreply@blogger.com (RemedyMD) — Tue, 08 Mar 2011 23:38:00 +0000

Recently we have closed three opportunities that are focused on collecting, harmonizing, and analyzing a wide variety of Multiple Sclerosis data. While each of these groups is focused on MS, they are approaching the problem from widely differing perspectives. One of these is a large independent research facility that is focused on the scientific and genomic aspects of MS. The second is a well-respected medical school, which is most interested in the clinical ramifications of MS. The third is a research and advocacy foundation that is focused on improving outcomes for patients and their families. Since all these registries will sit on top of the Mosaic™ Meta-Registry, cross-registry research will be a simple and logical next step. Of course collaboration between these groups can be greatly enhanced by their ability to share data that has already been harmonized by our ontology and is in a format that is consistent for all three groups.

It will be exciting to see how all this data from a variety of perspectives can be used to enhance the value of the data kept by each of the other organizations. We have always believed that by aggregating data from a variety of disparate sources we would be able to recognize patterns that are not possible to identify without many different sources. . As these three organizations begin to collect large amounts of data and as we close opportunities with other researchers interested in MS, I expect that some highly interesting patterns will emerge that will point the way for the next generation of MS research with a more narrow focus thus providing higher probability for success.

Soon we will have a chance to see if our value proposition is a important as we think it is.

Gary D. Kennedy - Founder and CEO -

Stem Cell Meetings

noreply@blogger.com (RemedyMD) — Wed, 23 Feb 2011 20:32:00 +0000

Just returned from the CIBMTR/ASBMT meetings in Hawaii. We introduced our new ComprehensiveBMT product for Blood and Marrow Transplants. Its obvious that HSCT is a major growth area for our software and for medicine in general. I can almost hear the old industrialist who told Dustin Hoffman to go into plastics telling a 2011 Graduate to go into "stem cells, that is the future".

The researchers and clinicians who are working in this area really need some new product options. They are mostly scientific types so they do not appreciate all the features of our products (ontology, dynamic revision of the data structure, configuration without programming, etc) but they really understand the benefits of being able to aggregate data from all sources to pull together a 360 degree view of each patient and they understand the pain from having one size fits all systems that cannot be customized to their individual needs. Yet they certainly do not want to enable some software company to tell them how to conduct their research. Could be a great opportunity to help these folks dramatically improve their research and clinical effectiveness.

Reading Tea Leafs of the Federal Budget

noreply@blogger.com (RemedyMD) — Wed, 16 Feb 2011 04:23:00 +0000

We have been waiting anxiously awaiting President Obama's proposed budget for FY 2012 to see what kind of signals he sent regarding spending priorities for the future. It was released yesterday and contained a reasonable increase for the National Institutes of Health compared to the decrease that had been suggested by House Republicans. The absolute amount of the increase is less important than the demonstration that the administration will continue to fund healthcare research.

We have been waiting to see if the funding priorities continued in the same direction before we decided to dedicate time and resources to the Accountable Care Organization (ACO) initiative. It appears that we have enough information that we can finish our ACO product and begin to sell to selected ACOs. While the exact specifications for ACOs are still under development our products are sufficiently flexible that we can configure them based on what we know now and then reconfigure them if the government takes a surprise turn.

Gary

RemedyMD Improves Google Visibility

noreply@blogger.com (RemedyMD) — Fri, 17 Dec 2010 17:16:00 +0000

In an effort to help build awareness about its products, tools, and applications, RemedyMD has launched new efforts to boost its visibility on Google with the creation of new destination pages such as this one for research management software. Several others are under development and are hoped to help with the proliferation of this revolutionary research management software founded on the Mosaic Meta-Registry platform.

Registries for Researchers: Would You Trade Your Toys For Clinical Data?

noreply@blogger.com (RemedyMD) — Tue, 02 Nov 2010 22:02:00 +0000

Wednesday, November 17, 2010 2:00 PM - 3:00 PM EST

Researchers say they would give almost anything to gain access to clinical data. Would they give up their toys? One of the largest impediments to effective research is the inability to make use of existing clinical data. Are you able to link your existing research data that is stored in spreadsheets or little Access databases with the clinical data you need to be dramatically more effective? Perhaps the problem is not with the clinical data but instead is the toy registry you are trying to link with the clinical data. “Toy” registries enable you to house data that has no validation, terminological harmonization, or mechanism to harmonize your research data with the other disparate source of data. No wonder researchers feel they are spending more time as database administrators than as clinical researchers. The strength of using toy systems such as spreadsheets for research is that you can dump any kind of data into them which also happens to be the major drawback.

This webinar will demonstrate the capabilities you can get from a real, robust registry. You will see how clinical data can be accessed regardless of where it is stored or the formats it is kept in, and how this data can be efficiently ‘normalized’ and validated so running queries or reports across any data elements is simple. Configuring data capture forms and reports is as simple as dragging and dropping data elements from our ontology. Researchers will dramatically accelerate their results once using a ‘real’ registry, whether that work is basic science research, clinical research, disease or outcomes research, comparative effectiveness studies, clinical trials, or medical device research.

Seeing this breakthrough technology in contrast with ‘toy’ registries, spreadsheets, or Access databases is vital for understanding the opportunity costs of using such systems and benefiting from making the change. Register today!

Translational Research Webinar Oct. 13th

noreply@blogger.com (RemedyMD) — Wed, 06 Oct 2010 21:05:00 +0000

Don't miss "Registries: The Missing Ingredient for Translational Research," Wed., Oct. 13th at 2 PM Eastern. (Visit https://www1.gotomeeting.com/register/189609424 to register today)

Join RemedyMD for this thought-provoking 60-minute online seminar about resolving obstacles in Translational Research—with guest presenters Kenneth Iczkowski, MD, and Gary D. Kennedy. Dr. Iczkowski is Associate Editor-in-Chief of the American Journal of Translational Research and serves as Associate Professor at the University Of Colorado Department Of Pathology. Gary D. Kennedy is Founder and CEO of RemedyMD, the leading registry software tools provider dedicated to helping advance translational research.

One of the greatest challenges impeding translational research is the inaccessibility of the data. This webinar will tackle the hard challenges that cause “the data problem”. In doing so we will explore the most common impediments to exchanging and leveraging data, and we will provide examples of a meta-registry model that enables translational researchers to aggregate all data from all sources into a single flexible structure which enables them to recognize patterns that ultimately lead to patient benefit.

Don't miss the opportunity to hear these two compelling speakers and learn how the right registry can easily bring all your clinical data, biospecimen repositories, imaging, research applications, gene panels, and RCT data to reveal a clearer picture of a patient. We'll also explain how registries manage ontological discrepancies when merging data and best practices for maintaining data integrity throughout the research life cycle. Read more about Dr. Iczkowski here.

Visit https://www1.gotomeeting.com/register/189609424 to register today.

Disease Registries: "Key to Finding Cure for Alzheimer's"

noreply@blogger.com (RemedyMD) — Tue, 01 Jun 2010 22:38:00 +0000

A disease registry, or disease registries, will be key to finding a cure or treatments to Alzheimer's Disease, according to a recent panel of 15 reviewers brought together by the NIH who looked at 250 human research studies and 25 papers about the disease. Some slight correlations between diet, exercise and mental activity were in the data but relationships were too small to be definitive, thus validating the need for disease registries. Comparative effectiveness research of different treatments in ongoing studies will continue over the coming 10 to 15 years. For more information visit http://www.livescience.com/health/alzheimers-prevention-100516.html.

Predictive Analytics and Clinical Decision Support

noreply@blogger.com (RemedyMD) — Fri, 21 May 2010 15:46:00 +0000

6 Reasons Why UniversalRegistry™ Technology is the Answer

What if your organization had more self-sufficient researchers, who could put together as many quality of care or outcomes studies as they wanted, or as many disease registries as they wanted, without having to go to IT for each and every study? How would it be for providers to collect and leverage data related to treatments and outcomes right at the point of care, for every combination of circumstances they encounter? And how would it be as the head of IT to be the one to implement such leading technology?

Whether any of the above situations applies to you, or you are doing clinical trials, or you’re a CRO, or even a medical device manufacturer…the future once envisioned where data drives everything is here, and the technology exists to do it all. And, it’s scalable and affordable.

Ask yourself, then, “If UniversalRegistry Technology is the answer, which six things does it accomplish to make it the answer?”

1. Access to your data. If you’re using Microsoft®, or ORACLE®, or some other SQL database, a trait of UniversalRegistry Technology is that it can connect to any system you need it to, so that it brings data together instead of introducing accessibility roadblocks from square one.

2. Speed of implementation. This technology lets clinicians, providers, or researchers be who they are, because IT staff can be who they are. Meaning it’s so quick to set-up, IT actually has time to squeeze in a few registries between their other umpteen projects and thus researchers and clinicians can focus on what they do best. By setting up one registry that forms the backbone of the system, an endless number of registries can be configured in just hours to fit any and every request.

3. Em-powerment to the people. For non-IT staff, UniversalRegistry Technology also means increased self-sufficiency from those who customize EDC forms, enter data, build queries, report on it; or import, export or “normalize” data for that matter. The end results are increased empowerment, less waiting, more actionable data, on less required bandwidth across all departments.

4. Aggregate data in 31+ flavors. View data in real-time from a single dashboard from the following sources to see the big picture: EHR software, online self-reporting portals, provider entered data, off-site research data, image data, CPT, ICD, LOINC, SnoMed, NormRx data, and more. If you didn’t anticipate needing a certain type, or format, or source of data, another trait of your UniversalRegistry is that it can adapt on-the-fly without skipping a beat.

5. Have it your way. And define the meaning of “it” while you’re at it. What this means is, this is not simply a matter of subtracting pickles off your burger and adding swiss. If one type of registry is a burger, you know your needs better than anyone and so maybe the registry itself that you need is a totally different animal, like Pei King Duck. UniversalRegistries provide the best of both worlds so you get exactly what you want, and then once you have it you can add and subtract requirements seamlessly.

6. Speaks the same language as you do. And they do. Even when they’re not the same. What this means is that if you entered data on the “flu” and he entered it as “influenza” and she entered it with strain information, a UniversalRegistry must contain a vast terminology layer that resolves these types of discrepancies correctly, in as automated a way as possible without compromising the data. It’s part of the heavy-lifting that makes this technology so powerful.

As 2010 draws to a close, this is the type of technology straight out of a Stanley Kubrick film, from the 1970s. It means UniversalRegistry Technology is an idea whose time has come in addition to comparative effectiveness research, and is actually overdue. As data, and the health sector and public sectors converge, so too are ideas from medical science fiction and our present day reality. RemedyMD are pioneers in this technology, and they have actively perfected UniversalRegistry Technology during the last 7 years.

Disease Registry White Paper Library

noreply@blogger.com (RemedyMD) — Wed, 28 Apr 2010 15:38:00 +0000

The new Web site for RemedyMD is live and has some great resources. There is a white paper library full of content about rare, common, patient, and clinical research registries (http://www.remedymd.com/registry-white-papers.php) as well as a podcast library and on-demand webcast library. These resources are all downloadable for free.

RemedyMD Rare Disease "RegistryOnDemand"

noreply@blogger.com (RemedyMD) — Wed, 14 Apr 2010 18:09:00 +0000

According to EURODIS, "The rare disease patient is the orphan of health systems, often without diagnosis, without treatment, without research, therefore without reason to hope."

"The lack of specific health policies and the scarcity of expertise translate into delayed appropriate diagnosis and difficulty of access to care. The national healthcare services for diagnosis, treatment and care of rare disease patients differ significantly in terms of their availability and quality. European citizens have unequal access to healthcare services and to orphan drugs. Research on rare diseases is scarce."

One of the best ways to fight rare diseases, a cause that is so near and dear to the hearts of those affected, is the sharing of data, treatments, outcomes and other research. RemedyMD (www.RemedyMD.com) has decided to help by offering tools for rare disease researchers to create rare disease registries where research information is entered, shared, and analyzed so cures can be found from this collective knowledgebase.

If you have a rare disease story to share please tell us about it here.

RemedyMD acquires EZHealthcare

noreply@blogger.com (RemedyMD) — Tue, 10 Jul 2007 22:04:00 +0000

We've recently acquired EZHealthcare, a company specializing in practice management software and solutions for revenue management. We feel like it's a great fit with our current suite of EHR products ... you can read more about it in our press release here.

RemedyMD Acquires EZHealthcare, a Leading Provider of Revenue Cycle Management Software and Services

SALT LAKE CITY, Utah – July 10, 2007 – RemedyMD®, Inc., the market leader in the use of predictive informatics to recognize patterns, personalize treatment and measurably improve healthcare outcomes, today announced it has signed a definitive agreement to acquire privately held EZHealthcare, Inc.®, a leading provider of automated revenue cycle management solutions. EZHealthcare, also headquartered in Salt Lake City, UT, was founded in 1988 and provides an award-winning practice management solution to over 1900 medical practices nationwide. The terms of the acquisition were not disclosed.

Customers of RemedyMD and EZHealthcare will both benefit as the companies merge to create a comprehensive and fully integrated clinical and revenue cycle solution. EZHealthcare's products will be web-enabled and utilize the RemedyMD Mosaic™ platform, providing the latest internet-based technology to EZHealthcare customers. EZ Office™, EZHealthcare's practice management suite, will be available to RemedyMD customers and to practices seeking to realize the ROI benefits available from an integrated clinical and revenue-cycle management system. EZ EHR™, a new Web-based EHR designed for primary care practices, will be offered to EZ Office customers. Practices that use EZ Office or EZ EHR, and their patients, will benefit from RemedyMD's industry-leading patient portal, myHealthManager™.

"Previously, we were able to assist our customers by capturing and leveraging detailed clinical data," said Gary Kennedy, President and CEO of RemedyMD. "Now, we can offer the best of both worlds: the best data to facilitate the best decisions that lead to optimal outcomes, and a revenue cycle management system that enables clinical documentation to drive correct coding levels as well as provides support for outcomes-oriented initiatives such as P4P and PQRI."

"We joined the RemedyMD family in order to provide a complete healthcare solution for practices and clinics," said Derek Cordon, President of EZ Healthcare. "We have always known that there would be a major advantage to practices that use integrated clinical and financial systems from the same vendor. We began to build the additional products we needed, but when we saw RemedyMD's platform it became obvious that we could better meet the needs of our customers by combining efforts."

"We've spent the last five years assembling a team of specialized product development talent and building one of the most advanced platforms available," said Roberto Rocha, RemedyMD's Chief Medical Officer and Lead Informaticist. "We can take the expertise and content developed by EZ Healthcare over all these years and immediately put it to work on our platform. This will help us provide one more element in our quest to provide a 360° view of all patients."

This strategic product and technology acquisition expands the breadth of the RemedyMD Mosaic™ platform. The acquisition is expected to give RemedyMD expanded market opportunities by providing new product entry-points as well as cross-sell opportunities. In addition, RemedyMD will use existing EZHealthcare staff to augment its team in management, client services, and sales. The new support team will be based in Burley, Idaho, which will become RemedyMD's nationwide support center. For more information, please visit www.RemedyMD.com.

Great Show at ASBS 2007

noreply@blogger.com (RemedyMD) — Sun, 24 Jun 2007 06:17:00 +0000

Just got back from the annual trip to ASBS... things were really clicking for us at the conference this year. Lots of good leads, great conversation with a lot of very interesting and important people. All said and done, it was a very positive conference for both our BariEHR product and Investigate for Bariatrics, our clinical outcomes research offering.

The conference was held at the San Diego Conference center, in gorgeous downtown San Diego, literally minutes from the airport. The weather was great (but then again, this is San Diego, would you expect less?) and people were very pleasant to talk with.

Dr. Phil Schauer, the outgoing president of ASBS, came to our booth on Thursday the 14th to talk about his experiences with RemedyMD at CCF, and how they've been using our product. We actually had quite a crowd packed in for that part of the session. I think that people are genuinely interested in conducting outcomes studies and improving their care processes to have better care, but often find themselves ill-equipped to do so. That's why we feel Investigate for Bariatrics adds so much value... let us handle the data management/security/collection, etc and spend your time focusing on the research.

We spoke with several groups wanting to aggregate data locally for research, others interested in developing registries and state-wide weight-loss surgery data sets. Investigate is a natural option to support these since it really focuses on three things 1) Aggregating data from multiple sources 2) Providing easy screen-building tools to support further data collection and 3) Offering powerful query and report generation tools to make use of this data. Our message was definitely resonating with the ASBS 2007 crowd...

Advisory Board Meeting at ASBS

noreply@blogger.com (RemedyMD) — Wed, 06 Jun 2007 17:26:00 +0000

Below is a press release talking about our upcoming events at ASBS... we're looking forward to a successful show...

SALT LAKE CITY, Utah – June 5, 2007 – RemedyMD®, leading provider of bariatric surgery-specific electronic health record products, announced that its fifth annual Bariatric Advisory Board meeting is scheduled for the morning of June 13th directly prior to the American Society of Bariatric Surgery (ASBS) annual conference at the Marriott Marina Hotel in San Diego. Advisory board members will discuss industry trends, best practices, product enhancements, and their practice-specific experiences with RemedyMD's bariatric products and services.

RemedyMD's EHR platform enables physicians and their staff to streamline practice workflow, document patient visits, record, report, and improve on health outcomes, receive clinical decision support, and facilitate better patient involvement in their own healthcare. BariEHR is specifically outfitted for bariatric surgeons by providing full documentation and management of initial visits, surgeries, and follow up care. BariEHR also enables full reporting for any certification or credentialing program, including but not limited to the Surgical Review Corporation's Centers of Excellence program, and insurance company-specific Centers of Excellence and Distinction programs.

As with all RemedyMD solutions, BariEHR includes myHealthManager™, RemedyMD's web-based weight-loss management solution for patients. myHealthManager is a comprehensive patient health and wellness management system that facilitates patient registration, nutrition, weigh-ins, exercise journaling and goal-setting. myHealthManager displays surgeon-created reminders and secure messages directly to patients. Patients can access online educational resources and participate in an active weight-loss community. Statistics show that patients who utilize myHealthManager are more likely to stay on track with their weight-loss programs, maintain long-term contact with the practice, and ultimately lose more weight.

“We meet with top accredited bariatric surgeons each year to gather feedback and implement it into BariEHR,” said Emily Bonham, RemedyMD's Director of EHR Products and Bariatric Advisory Board Chair. “The surgeons' input is crucial to our product development strategy, and helps us continue to provide bariatric surgeons and their patients with the most advanced bariatric electronic health records software on the market today.”

In addition to the BariEHR Advisory Board meeting, RemedyMD will be exhibiting at the ASBS conference in San Diego June 13-15, 2007, Booth #623. For more information, please visit www.BariEHR.com/.